CD8A and neoplasm: Ruijter et al. demonstrated that immuno-PET using 89Zr-labeled CD8-specific one-armed antibody (89ZED88082A) detected its accumulation within the tumor lesions in patients with deficiency of mismatch repair (dMMR) tumors, and its accumulation was consistent with the CD8 IHC expression pattern [83].